RH
Therapeutic Areas
Aspen Pharmacare Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Sterile Injectables Portfolio | Anaesthetics, Cytotoxic Oncology, Anti-coagulants | Commercial & Development |
| Biosimilars Program | Immunology, Oncology | Development & Commercial |
| Oral Solid Dose & OTC Portfolio | Various (CNS, Cardiovascular, Respiratory, Consumer Health) | Commercial & Line Extensions |
| Thrombosis Portfolio | Treatment & Prophylaxis of Thromboembolic Disorders | Commercial |
| Anaesthetics Portfolio | General and Local Anaesthesia | Commercial |
| Infant Nutritionals | Maternal & Child Nutrition | Commercial |
Leadership Team at Aspen Pharmacare
SS
Stephen Saad
Group Chief Executive
KD
Kuseni Dlamini
Board Chair
SC
Sean Capazorio
Group Chief Financial Officer
GA
Gus Attridge
Group Chief Advisor
LH
Lorraine Hill
Group Chief Operations Officer
SK
Samer Kassem
Chief Executive Officer, Aspen Global Incorporated
SN
Stavros Nicolaou
Group Senior Executive Strategic Trade
BK
Ben Kruger
Lead Independent Non-executive Director
LD
Linda de Beer
Independent Non-executive Director